| Value | ₹18.00 Cr |
|---|
BSE filing, NSE: INTERCONTINENTAL. Summary written from the filing by ALFA Finder's alert engine.
Medico Intercontinental Ltd: key numbers
- Share price
- ₹27.21
- Market cap
- ₹27.21 Cr
- Revenue (annual)
- ₹84.08 Cr
- Net profit (annual)
- ₹-11.09 Cr
- P/E (TTM)
- -16.2×Sector 46.8×
- Promoter holding
- 58.51%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medico Intercontinental Ltd
All →Medico Intercontinental Q2 FY27 Results: Net Profit ₹0 Cr
Medico Intercontinental Ltd reported revenue from operations of ₹22.8 Cr (+11.8% YoY) and net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Medico Intercontinental Board Meeting Date
Medico Intercontinental has scheduled a board meeting for November 6, 2026 to consider unaudited financial results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after the results.
Medico Intercontinental Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Medico Intercontinental Annual General Meeting
Medico Intercontinental Limited conducted its 42nd Annual General Meeting on September 30, 2026. Shareholders considered the adoption of FY26 financial statements and approved several related party transactions.
Medico Intercontinental Annual General Meeting
Medico Intercontinental Ltd will convene its Annual General Meeting on September 30, 2026. The company announced book closure from September 24 to September 30, 2026.
Medico Intercontinental Q1 FY27 Results: Net Loss of ₹4 Cr, Loss Widens
Medico Intercontinental Ltd reported revenue from operations of ₹20.7 Cr (-3.3% YoY) and a net loss of ₹4 Cr for Q1 FY27.
- Key figure
- Net loss ₹4 Cr
Other debt & borrowing announcements
All →HDFC Life Insurance Company Debt & Borrowing
HDFC Life intimated a CRC meeting on November 16, 2026, to approve commercial terms for up to ₹500 Crore of unsecured subordinated NCDs. The filing only schedules the meeting; no terms are yet approved.
Repco Home Finance Debt & Borrowing
Repco Home Finance submitted a revised Security Cover and Covenant Compliance Certificate as of 30 September 2026, extending compliance coverage to all Debenture Trust Deed covenants. The revision follows the earlier certificate and only changes the covenant scope and UDIN.
Triveni Turbine Debt & Borrowing: ₹56.21 Cr
Triveni Turbine enhanced its corporate guarantee for subsidiary TTAPL by USD 6 million. Guarantee amount is Rs.56.21 Crore, lifting the facility limit to USD 15 million.
- Value
- ₹56.21 Cr
TSF Investments Debt & Borrowing
TSF Investments' board approved up to ₹1,500 Crore in debt instruments of group companies. The material related-party deal needs shareholder approval via postal ballot.
Motilal Oswal Financial Services Debt & Borrowing: ₹150 Cr
Motilal Oswal Financial Services certified timely payment of the Rs.150 Crore maturity on commercial paper ISIN INE338I14NE7, due 11 November 2026. This confirms fulfilment of a debt obligation.
- Value
- ₹150.0 Cr
Glottis Debt & Borrowing: ₹60 Cr
Glottis's board approved up to ₹60 Crore of interest-free unsecured loans from two Managing Directors. The related-party loans fund working capital and are not at arm's length.
- Value
- ₹60.00 Cr
- Execution
- Up to 5 years from each tranche disbursement